Provided by Tiger Trade Technology Pte. Ltd.

Apimeds Pharmaceutical U.S, Inc.

5.02
-0.4900-8.89%
Post-market: 7.742.72+54.18%18:13 EDT
Volume:1.21M
Turnover:5.97M
Market Cap:7.58M
PE:-0.13
High:5.72
Open:5.54
Low:4.40
Close:5.51
52wk High:59.70
52wk Low:1.51
Shares:1.51M
Float Shares:725.94K
Volume Ratio:0.06
T/O Rate:166.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.5450
EPS(LYR):-0.1759
ROE:-144.99%
ROA:-69.29%
PB:0.93
PE(LYR):-28.55

Loading ...

Mindwave Innovations Signs 3 Client Network Agreements in 10 Days, Extending Mindchain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure

THOMSON REUTERS
·
14 mins ago

Amex Halt Add Info Lst 4.940000

THOMSON REUTERS
·
Oct 05

Mindwave Innovations Signs Agreement with US-Based Blockassure to Build and Operate Assurechain, an End-to-End Insurance and Reinsurance Network

THOMSON REUTERS
·
Oct 05

Apimeds Pharmaceuticals Appoints Eric Sherb as New CFO

TIPRANKS
·
Oct 01

Apimeds Pharmaceuticals US - Appoints Eric Sherb as Chief Financial Officer Effective October 1, 2026 - SEC Filing

THOMSON REUTERS
·
Oct 01

MindWave expands blockchain services into sports media markets

TIPRANKS
·
Sep 30

Apimeds Unit MindWave Innovations to Deploy MindChain Blockchain for AQUAEChain Platform

Reuters
·
Sep 30

Mindwave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate Flashchain for New York-Based Flash Sports & Media

THOMSON REUTERS
·
Sep 29

Mindwave Innovations: Parties Have not Publicly Disclosed Aggregate Dollar Value of Consideration Under Agreement.

THOMSON REUTERS
·
Sep 29

Amex Halt Add Info Lst 7.920000

THOMSON REUTERS
·
Sep 25

Top Midday Gainers

MT Newswires Live
·
Sep 25

Why Is Apimeds Pharmaceuticals US Stock (APUS) Up Today?

TIPRANKS
·
Sep 25

Mindwave Innovations Signs Agreement to Build and Operate Aquaechain, a Platform for Insured Alci Credits

THOMSON REUTERS
·
Sep 24

Apimeds Pharmaceuticals US - Enters First Amendment to Settlement Agreement on Sept 10, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 11

Apimeds Pharmaceuticals US - Board to Consist Solely of Four Members During Interim Period - SEC Filing

THOMSON REUTERS
·
Sep 11

Apimeds Pharmaceuticals US - Board to Expand to Seven Members After Interim Period - SEC Filing

THOMSON REUTERS
·
Sep 11

Apimeds Pharmaceuticals Adds Co-CEO Sungjoon Chae to Board

Reuters
·
Sep 11

Apimeds Pharmaceuticals US Enters Assignment and Transfer Agreement with Freet on August 19

Reuters
·
Aug 22

Apimeds Secures Key Apitox Rights via FreeT Agreement

TIPRANKS
·
Aug 22

Apimeds Pharmaceuticals US - Freet Assigns All Apitox-Related Rights to Apimeds Pharmaceuticals - SEC Filing

THOMSON REUTERS
·
Aug 22